Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial

Brian J. Wainger*, Eric A. Macklin, Steve Vucic, Courtney E. McIlduff, Sabrina Paganoni, Nicholas J. Maragakis, Richard Bedlack, Namita A. Goyal, Seward B. Rutkove, Dale J. Lange, Michael H. Rivner, Stephen A. Goutman, Shafeeq S. Ladha, Elizabeth A. Mauricio, Robert H. Baloh, Zachary Simmons, Lindsay Pothier, Sylvia Baedorf Kassis, Thuong La, Meghan HallArmineuza Evora, David Klements, Aura Hurtado, Joao D. Pereira, Joan Koh, Pablo A. Celnik, Vinay Chaudhry, Karissa Gable, Vern C. Juel, Nicolas Phielipp, Adel Marei, Peter Rosenquist, Sean Meehan, Björn Oskarsson, Richard A. Lewis, Divpreet Kaur, Evangelos Kiskinis, Clifford J. Woolf, Kevin Eggan, Michael D. Weiss, James D. Berry, William S. David, Paula Davila-Perez, Joan A. Camprodon, Alvaro Pascual-Leone, Matthew C. Kiernan, Jeremy M. Shefner, Nazem Atassi, Merit E. Cudkowicz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences